| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/15/2006 | CN1245169C Memory and perception improving pure natural composite preparation and its preparing process |
| 03/15/2006 | CN1245168C Storax and baras camphor oral disintegration tablet and its preparing process |
| 03/15/2006 | CN1245166C Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 03/15/2006 | CN1245165C Preparation method and uses of hyaluronic acid gel with iron ion and medicine used for preventing adhesion after operation |
| 03/15/2006 | CN1245163C Puerarin dispersing tablet composition and its preparation method |
| 03/15/2006 | CN1245160C Compound pressure-reduction preparation containing indapamide and angiotensin converzyme inhibitor |
| 03/15/2006 | CN1245158C 片剂组合物 Tablet composition |
| 03/15/2006 | CN1245156C Methods for in vivo delivery of biologics and compositions therefor |
| 03/15/2006 | CN1245155C Oral pharmaceutical pulsed release dosage form |
| 03/15/2006 | CN1245154C Mouth cavity fast disintegrating tablet of Chinese medicine or natural medical matters and its preparing method |
| 03/15/2006 | CN1245153C Vitamin A liposome and its preparation method |
| 03/15/2006 | CN1245152C Nano-silver aqueous solution preparation and its uses |
| 03/15/2006 | CN1245106C Arctium lappa capsule and method for making it |
| 03/15/2006 | CA2515626A1 Pharmaceutical dosage forms with impeded extractability of a sympathomimetic from the dosage form |
| 03/14/2006 | US7012092 Formulation and delivery method to enhance antioxidant potency of Vitamin E |
| 03/14/2006 | US7012072 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same |
| 03/14/2006 | US7012068 Reduced toxicity; enhance efficiency; side effect reduction |
| 03/14/2006 | US7011968 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 03/14/2006 | US7011963 Process for synthesis of bead-shaped cross-linked hydrophilic support polymer |
| 03/14/2006 | US7011855 Biochemically balanced peritoneal dialysis solutions |
| 03/14/2006 | US7011851 Drug delivery; incontinence therapy |
| 03/14/2006 | US7011850 Dosage forms having a barrier layer to laser ablation |
| 03/14/2006 | US7011849 Second release phase formulation |
| 03/14/2006 | US7011848 Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 03/14/2006 | US7011847 Enteric coated formulation for bisphosphonic acids and salts thereof |
| 03/14/2006 | US7011846 Oral capsule formulation with increased physical stability |
| 03/14/2006 | US7011845 For therapy and prophylaxis of infection or tumor |
| 03/14/2006 | US7011844 Formulations for the administration of fluoxetine |
| 03/14/2006 | US7011843 Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system |
| 03/14/2006 | US7011841 High density porous materials |
| 03/14/2006 | US7011825 Erythropoietin solution preparation |
| 03/14/2006 | US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route |
| 03/14/2006 | US7011819 Increasing the rate at which the peak plasma concentrations are reached by delivering the drug in a single inspiration from a dispenser in which the condensation aerosol was formed by cooling a vapor formed by heating a thin layer on a support; less than 10% degradation products and a mass median aerosol |
| 03/14/2006 | US7011818 Promotes the release of the active particles from the carrier particles on actuation of the inhaler; efficiency |
| 03/14/2006 | US7011776 Method and apparatus for preparing microspheres |
| 03/14/2006 | US7011093 Nasal dilators and strips, methods of their manufacture, and methods for improving the breathing of individuals are provided. The strips and dilators include an elongated substrate, with or without a dilating component or portion, |
| 03/14/2006 | CA2312710C Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| 03/14/2006 | CA2286096C Heat resistant lipid vesicles |
| 03/14/2006 | CA2206333C Novel anthracycline compound derivative and pharmaceutical preparation containing the same |
| 03/14/2006 | CA2127166C Sustained release morphine compositions and a method of preparation |
| 03/09/2006 | WO2006026768A1 Multi-cap reservoir devices for controlled release or exposure of reservoir contents |
| 03/09/2006 | WO2006026592A2 Oral administration of poorly absorbed drugs, methods and compositions related thereto |
| 03/09/2006 | WO2006026556A2 Bioadhesive rate-controlled oral dosage formulations |
| 03/09/2006 | WO2006026502A1 Enhanced delivery of drug compositions to treat life threatening infections |
| 03/09/2006 | WO2006026501A1 New pharmaceutical compositions for the treatment of cancer |
| 03/09/2006 | WO2006026500A1 New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders |
| 03/09/2006 | WO2006026469A2 Pharmaceutical formulations of potassium atp channel openers and uses thereof |
| 03/09/2006 | WO2006026299A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b and other therapeutic proteins |
| 03/09/2006 | WO2006026215A1 Compositions containing alpha-2-adrenergic agonist components |
| 03/09/2006 | WO2006026174A2 Matrix composition for stable microemulsions |
| 03/09/2006 | WO2006026083A2 Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids |
| 03/09/2006 | WO2006026040A1 Polymeric film |
| 03/09/2006 | WO2006025786A1 Molded micro-needles |
| 03/09/2006 | WO2006025583A1 External preparation of s/o type |
| 03/09/2006 | WO2006025411A1 Liposome improving intracellular drug delivery |
| 03/09/2006 | WO2006025395A1 Drug and treating system for chronic obstructive pulmonary disease by using carrier-free cell growth factor |
| 03/09/2006 | WO2006025324A1 Tropan compound |
| 03/09/2006 | WO2006025029A2 Extended release composition of divalproex |
| 03/09/2006 | WO2006024944A2 Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| 03/09/2006 | WO2006024881A2 Multiparticulates of preferably an opioid, and method of manufacturing using extrusion |
| 03/09/2006 | WO2006024675A1 Use of alkylphospholipids for the treatment of solid tumours |
| 03/09/2006 | WO2006024638A2 Peroral dosage forms to achieve a sustained-release effect after medicament dosage with a meal |
| 03/09/2006 | WO2006024492A2 Medical implant provided with inhibitors of atp synthesis |
| 03/09/2006 | WO2006024491A1 Methods and compositions for the treatment of cell proliferation |
| 03/09/2006 | WO2006024490A2 Methods and compositions for the treatment of cell proliferation |
| 03/09/2006 | WO2006024489A2 Methods and compositions for the treatment of cell proliferation |
| 03/09/2006 | WO2006024488A2 Medical stent provided with inhibitors of atp synthesis |
| 03/09/2006 | WO2006024479A2 Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin |
| 03/09/2006 | WO2006024357A2 Use of statistical copolymers as dispersants |
| 03/09/2006 | WO2006024339A2 Controlled-release multilayer patch for the topical use |
| 03/09/2006 | WO2006024284A2 Atrium patch |
| 03/09/2006 | WO2006024122A1 Immunogenic compositions |
| 03/09/2006 | WO2005120459A3 Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same |
| 03/09/2006 | WO2005115418A9 New hydroxapatite calcium phosphates, their method of preparation and their applications |
| 03/09/2006 | WO2005115358A3 Intranasal delivery of nucleic acid molecules |
| 03/09/2006 | WO2005110363A3 Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles |
| 03/09/2006 | WO2005051368A3 Phosphodiesterase v inhibitor formulations |
| 03/09/2006 | WO2005040228A3 Disintegratable films for diagnostic devices |
| 03/09/2006 | WO2005036996A3 Polymeric glove with lotion coating and method of making same |
| 03/09/2006 | WO2005027872A3 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
| 03/09/2006 | WO2005018685A3 System and apparatus for remote activation of implantable medical devices |
| 03/09/2006 | US20060052768 Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method |
| 03/09/2006 | US20060052441 Dosage form of polysaccharides, especially cocoa extracts, containing procyanidine units an additional nitric oxide modulating agent; dietary supplements; pet foods |
| 03/09/2006 | US20060052432 Pharmaceutical compositions with improved dissolution |
| 03/09/2006 | US20060052389 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/09/2006 | US20060052352 Mixtures or organic compounds for the treatment of airway diseases |
| 03/09/2006 | US20060052341 Control of a biological function |
| 03/09/2006 | US20060052340 Ophthalmic solution |
| 03/09/2006 | US20060052336 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052306 GRAS composition for enhanced mucosal delivery of parathyroid hormone |
| 03/09/2006 | US20060052305 Method of treating osteoporosis using intranasal parathyroid hormone |
| 03/09/2006 | US20060052298 Use of stable glutamine derivatives to improve drug absorption |
| 03/09/2006 | US20060052270 Solid dispersion compositions |
| 03/09/2006 | US20060051867 Cell growth |
| 03/09/2006 | US20060051479 Homogeneous solid granules containing carotenoids |
| 03/09/2006 | US20060051434 Cleaning tool |
| 03/09/2006 | US20060051431 Methods of managing multi-tissue injuries |
| 03/09/2006 | US20060051427 bioactive glass particles capable of inducing bone growth individually microencapsulated with a coating comprising a biodegradable polymer; the mass ratio of bioactive particles to coating ranges from 1:2-10:1; dry, granular composition when wetted forms a syringeable paste capable of repairing bone |
| 03/09/2006 | US20060051426 Nanoparticles containing polymeric nucleic acid homologs pharmaceutical composition and articles of manufacture containing same and methods of use thereof |